217 related articles for article (PubMed ID: 11363248)
1. Detecting CMV retinitis: know what to look for. Treatment is effective but not pleasant.
AIDS Alert; 1996 Mar; 11(3):suppl 1-2. PubMed ID: 11363248
[TBL] [Abstract][Full Text] [Related]
2. Advances in treatment for cytomegalovirus retinitis.
Bowers M
BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy improves CMV treatment.
AIDS Alert; 1996 Mar; 11(3):32-3. PubMed ID: 11363244
[TBL] [Abstract][Full Text] [Related]
4. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
5. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
6. The eyes have it, too.
Neger RE
Posit Aware; 1996; 7(3):10-1. PubMed ID: 11363423
[TBL] [Abstract][Full Text] [Related]
7. Oral ganciclovir.
Schouten JT
STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
[TBL] [Abstract][Full Text] [Related]
8. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
9. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
10. Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial.
Jabs DA
Antiviral Res; 1996 Jan; 29(1):69-71. PubMed ID: 8721550
[TBL] [Abstract][Full Text] [Related]
11. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
12. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
[No Abstract] [Full Text] [Related]
13. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
Jacobson MA
AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
[No Abstract] [Full Text] [Related]
14. New developments in the delivery of ganciclovir for cytomegalovirus (CMV retinitis).
Woodward J
STEP Perspect; 1995; 7(2):2-4. PubMed ID: 11362720
[TBL] [Abstract][Full Text] [Related]
15. CMV treatment.
Treat Rev; 1995; (no 19):4. PubMed ID: 11362756
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of CMV.
Cheng B
PI Perspect; 1995 May; (no 16):12-3. PubMed ID: 11362420
[TBL] [Abstract][Full Text] [Related]
17. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
18. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitors linked to drop in CMV retinitis.
AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
[TBL] [Abstract][Full Text] [Related]
20. FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration.
Baker R
BETA; 1995 Dec; ():8. PubMed ID: 11363015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
